Patents by Inventor Julia Hepp

Julia Hepp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTISPECIFIC PROTEINS
    Publication number: 20240190999
    Abstract: This disclosure relates to multispecific recombinant proteins useful for the treatment of cancer.
    Type: Application
    Filed: September 1, 2023
    Publication date: June 13, 2024
    Inventors: Christian REICHEN, Alexander LINK, Julia HEPP, Victor LEVITSKY
  • RECOMBINANT 4-1BB BINDING PROTEINS AND THEIR USE
    Publication number: 20220298212
    Abstract: The present disclosure relates to recombinant binding proteins comprising a designed ankyrin repeat domain with binding specificity for 4-1 BB (CD 137). In addition, the disclosure relates to nucleic acids encoding such binding proteins, pharmaceutical compositions comprising such binding proteins or nucleic acids, and the use of such binding proteins, nucleic acids or pharmaceutical compositions in methods for activating 4-1 BB in cells expressing 4-1 BB, e.g., tumor-localized T-lymphocytes, and for treating or diagnosing diseases, such as cancer, in a mammal, including a human.
    Type: Application
    Filed: June 3, 2020
    Publication date: September 22, 2022
    Inventors: Christian REICHEN, Alexander LINK, Julia HEPP, Victor LEVITSKY
  • MULTISPECIFIC PROTEINS
    Publication number: 20200385488
    Abstract: This disclosure relates to multispecific recombinant proteins useful for the treatment of cancer.
    Type: Application
    Filed: June 3, 2020
    Publication date: December 10, 2020
    Inventors: Christian Reichen, Alexander Link, Julia Hepp, Victor Levitsky
  • Antibody neutralizers of human granulocyte macrophage colony stimulating factor
    Patent number: 9067993
    Abstract: The present invention relates to a human monoclonal antibody or fragment thereof which specifically binds to and neutralizes primate GM-CSF.
    Type: Grant
    Filed: August 4, 2011
    Date of Patent: June 30, 2015
    Assignee: AMGEN RESEARCH (MUNICH) GMBH
    Inventors: Tobias Raum, Julia Hepp, Eva Vieser, Silke Petsch, Steven Zeman, Andreas Wolf, Sandra Bruckmaier